DNB Asset Management AS Raises Stock Holdings in Xenon Pharmaceuticals Inc. - Defense World

XENE Stock  USD 38.52  1.10  2.78%   
About 61% of Xenon Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Xenon Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Xenon Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Xenon Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
DNB Asset Management AS Raises Stock Holdings in Xenon Pharmaceuticals Inc. Defense World

Read at news.google.com
Google News at Macroaxis
  

Xenon Pharmaceuticals Fundamental Analysis

We analyze Xenon Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xenon Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xenon Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Xenon Pharmaceuticals is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Xenon Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Xenon Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Xenon Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Xenon Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Xenon Pharmaceuticals Related Equities

REPLReplimune   16.86   
0%
100.0%
VTYXVentyx Biosciences   6.88   
0%
40.0%
ANABAnaptysBio   6.50   
0%
38.0%
VRDNViridian Therapeutics   6.27   
0%
37.0%
MGTXMeiraGTx Holdings   5.56   
0%
32.0%
IDYAIdeaya Biosciences   4.37   
0%
25.0%
CRNXCrinetics Pharmaceuticals   3.78   
0%
22.0%
PCVXVaxcyte   3.36   
0%
19.0%
KROSKeros Therapeutics   3.23   
0%
19.0%
UTHRUnited Therapeutics   2.52   
0%
14.0%
ASNDAscendis Pharma   2.29   
0%
13.0%
MRUSMerus BV   0.74   
0%
4.0%
CYTKCytokinetics   0.17   
0%
1.0%
ACLXArcellx   0.14   
0%
1.0%
NUVLNuvalent   0.20   
1.0%
0%
INBXInhibrx   0.37   
2.0%
0%
LYELLyell Immunopharma   1.72   
10.0%
0%
EWTXEdgewise Therapeutics   1.72   
10.0%
0%
KRONKronos Bio   1.98   
11.0%
0%
DYNDyne Therapeutics   4.33   
25.0%
0%

Complementary Tools for Xenon Stock analysis

When running Xenon Pharmaceuticals' price analysis, check to measure Xenon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xenon Pharmaceuticals is operating at the current time. Most of Xenon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xenon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xenon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xenon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing